Welcome to our dedicated page for Hanover Bancorp SEC filings (Ticker: HNVR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Hanover Bancorp, Inc. keeps its edge in community banking by balancing a sizable multi-family mortgage book with stable local deposits. Investors often scan the company’s 10-K to gauge net interest margin, allowance for loan losses, and geographic concentration. If you’ve ever searched online for “Hanover Bancorp SEC filings explained simply,” this page is built for you.
Stock Titan’s AI instantly breaks down each Hanover Bancorp annual report 10-K simplified, highlights credit quality trends in the Hanover Bancorp quarterly earnings report 10-Q filing, and decodes any Hanover Bancorp 8-K material events explained within minutes of hitting EDGAR. Need to follow management moves? Receive Hanover Bancorp Form 4 insider transactions real-time as well as detailed alerts on Hanover Bancorp executive stock transactions Form 4. Our platform also points straight to the Hanover Bancorp proxy statement executive compensation so you can see how leadership is paid relative to peers.
Whether you’re stress-testing loan growth scenarios, measuring branch efficiency, or tracking community lending incentives, understanding Hanover Bancorp SEC documents with AI saves hours. Dashboards link every Hanover Bancorp earnings report filing analysis to interactive charts, while watchlists keep Hanover Bancorp insider trading Form 4 transactions in view before market opens. Real-time feeds, AI-powered summaries, and side-by-side comparisons ensure you move from document to decision without combing through 200 pages of footnotes.
Hanover Bancorp, Inc. furnished an investor presentation under Item 7.01 (Regulation FD) via an 8‑K. The presentation is attached as Exhibit 99.1 and is incorporated by reference in this report. The company notes the materials are being furnished, not filed under the Exchange Act, and therefore are not automatically incorporated into any Securities Act registration statement unless expressly identified there.
The event date is November 11, 2025. Hanover’s common stock trades on NASDAQ under the symbol HNVR. The report was signed by Executive Vice President and Chief Financial Officer Lance P. Burke.
Hanover Bancorp, Inc. (HNVR) reported Q3 2025 results. Net income was $3,491 versus $3,539 a year ago, with basic and diluted EPS of $0.47 versus $0.48. Net interest income rose to $15,223 from $13,102 as interest expense declined to $17,771 from $21,011. The provision for credit losses increased to $1,325 from $200. Non‑interest income was $2,785 versus $3,954, including a gain on sale of loans held‑for‑sale of $1,451 versus $2,834. Total non‑interest expense was $12,013 versus $12,238; earlier in 2025 the company recorded approximately $3,200 of one‑time core conversion costs.
For the nine months, net income was $7,455 versus $8,444. The balance sheet expanded modestly: total assets were $2,331,580 versus $2,312,110 at December 31, 2024. Deposits were $1,974,823 versus $1,954,283, and loans, net, were $1,966,329 versus $1,962,745. Accumulated other comprehensive loss improved to $(778) from $(1,334). Securities available‑for‑sale were $100,037. Common shares outstanding were 7,192,390 as of October 31, 2025.
Hanover Bancorp (HNVR) director reported an open-market sale of 5,000 shares of common stock on 11/04/2025 at $21.2495 per share.
Following the transaction, reported beneficial ownership includes 24,676 shares held directly and multiple indirect positions. Examples include 80,769 shares held in various trusts for a sibling (trustee role noted), 196,558 shares held in trusts for the reporting person (spouse as trustee), and stakes via entities and family trusts as detailed in the footnotes.
Hanover Bancorp, Inc. (HNVR) announced its earnings for the period ended September 30, 2025. The company furnished a press release as Exhibit 99.1 under Item 2.02. The information is provided pursuant to General Instruction B.2. of Form 8-K and is treated as “furnished,” not “filed,” under the Exchange Act.
Hanover Bancorp reported stronger quarterly results for the period ended June 30, 2025. Net income was $2.443 million versus $0.844 million a year earlier, and diluted earnings per share were $0.33 versus $0.11. Net interest income rose to $14.795 million from $13.247 million, helping drive improved profitability despite higher non-interest expense.
Loans totaled $1.966 billion, down slightly from $1.986 billion, and the allowance for credit losses was $21.571 million versus $22.779 million. Total deposits were $1.951 billion and total assets were $2.312 billion. The company completed a core data processing conversion in February 2025 that generated approximately $3.2 million of non-recurring expenses.
Hanover Bancorp (HNVR) Form 4: EVP & CFO Lance P. Burke reported a Code F withholding transaction on 1 Aug 2025 related to the vesting of prior-granted restricted stock. The company withheld 540 common shares at an average price of $20.81 to satisfy payroll-tax obligations, reducing Burke’s direct holdings from 26,497 to 25,957 shares. No open-market buying or selling occurred; the shares were automatically surrendered to the issuer, so the transaction does not reflect a discretionary investment view. Following the withholding, Burke retains an equity stake worth roughly $540k at the reported price, continuing to align his interests with shareholders.
The filing is routine, signals no change in corporate outlook, and involves fewer than 0.1 % of HNVR’s ~9.9 m shares outstanding. Liquidity or control implications are negligible.
Hanover Bancorp (NASDAQ: HNVR) filed an 8-K announcing completion of a re-incorporation merger, shifting its legal domicile from New York to Maryland on June 25 2025.
Key highlights:
- Each outstanding common and Series A preferred share converted 1-for-1 into equivalent Maryland-issued shares; trading continues under HNVR on Nasdaq starting June 26.
- Authorized capital unchanged at 17 million common and 15 million preferred shares; all options and warrants converted proportionally.
- All assets, liabilities, directors and officers carried over; SEC reporting continues.
- Corporate governance now falls under the Maryland General Corporation Law; new Articles & Bylaws filed as Exhibits 3.1-3.2.
- Transaction approved by shareholders on Jan 23 2024 and boards on Dec 20 2023 & Jun 25 2025; exempt from Securities Act registration via Rule 145(a)(2).
The filing triggers Items 1.01, 2.01, 3.03 and 5.03, marking a governance change without altering economic rights or financial condition.